# Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

> **NCT05983991** · NA · RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 150 (estimated)

## Conditions studied

- GATA2 Gene Mutation

## Interventions

- **OTHER:** Biological samples (blood and bone marrow samples).

## Key facts

- **NCT ID:** NCT05983991
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-07
- **Primary completion:** 2033-12
- **Final completion:** 2033-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05983991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05983991, "Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05983991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*